호흡기 3D 조직모델(SoluAirway™)의 품질과 독성평가에 대한 국내 확립 연구
Establishment Study on Quality and Toxicity Testing of Respiratory 3D Tissue Model (SoluAirway TM ) in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The concern of health and safety is growing due to increasing exposure of inhalable chemicals. However, there is no appropriate alternative testing method for assessing the hazard caused by inhalation exposure. The aim of this study is to establish respiratory 3-dimentional (3D) tissue model which can be applied for assessing the toxicity testing in Korea. First of all, respiratory 3D tissue model, SoluAirway™ was reconstituted by using human nasal mucosa. For evaluating its stability, the viability, Trans-Epithelial Electric Resistance (TEER), and histology was analyzed after delivered to 3 areas in Korea. Then, bleomycin (BLM) and polyhexamethylene guanidine phosphate (PHMG) which were known as toxic materials in pulmonary system were treated to various 3D tissue models to demonstrate applicability in evaluating chemical toxicity. The cytotoxicity and secretion of inflammatory cytokines was acquired with MTT and ELISA, respectively. The cell viability, TEER and integrity of the 3D tissue model which quality was controlled between products, had no significantly different values after delivery. The cytotoxicity of BLM and PHMG showed dose-dependently. Furthermore, the secretion of IL-8 was shown at the highest concentration of BLM and PHMG-p in SoluAirway™, not in EpiAirway™. When applied to KeraSkin™ which was a skin model, the secretion of IL-8 was declined. Taken together, these data showed that SoluAirway™ could be used as toxicity testing model for inhalable substances in Korea.
Abstract
The concern of health and safety is growing due to increasing exposure of inhalable chemicals. However, there is no appropriate alternative testing method for assessing the hazard caused by inhalation exposure. The aim of this study is to establish respiratory 3-dimentional (3D) tissue model which can be applied for assessing the toxicity testing in Korea. First of all, respiratory 3D tissue model, SoluAirway™ was reconstituted by using human nasal mucosa. For evaluating its stability, the viability, Trans-Epithelial Electric Resistance (TEER), and histology was analyzed after delivered to 3 areas in Korea. Then, bleomycin (BLM) and polyhexamethylene guanidine phosphate (PHMG) which were known as toxic materials in pulmonary system were treated to various 3D tissue models to demonstrate applicability in evaluating chemical toxicity. The cytotoxicity and secretion of inflammatory cytokines was acquired with MTT and ELISA, respectively. The cell viability, TEER and integrity of the 3D tissue model which quality was controlled between products, had no significantly different values after delivery. The cytotoxicity of BLM and PHMG showed dose-dependently. Furthermore, the secretion of IL-8 was shown at the highest concentration of BLM and PHMG-p in SoluAirway™, not in EpiAirway™. When applied to KeraSkin™ which was a skin model, the secretion of IL-8 was declined. Taken together, these data showed that SoluAirway™ could be used as toxicity testing model for inhalable substances in Korea.
참고문헌 (14)
- DeForge LE, "Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood", Biochemical and Biophysical Research Communications, 174(1), pp.18~24 (1991)
- Gon Y, "N-acetyl-L-cysteine inhibits bleomycin-induced interleukin-8 secretion by bronchial epithelial cells", Respirology, 5(4), pp.309~313 (2000)
- He Y, "Pingyangmycin and bleomycin share the same cytotoxicity pathway", Molecules, 21(7), pp.E862~ (2016)
- Ihekwereme C, "Preliminary studies on validation of calu-3 cell line as a model for screening respiratory mucosa irritation and toxicity", Pharmaceutics, 6(2), pp.268~280 (2014)
- Jackson GR Jr, "Prevalidation of an acute inhalation toxicity test using the EpiAirway in vitro human airway model", Applied In Vitro Toxicology, 4(2), pp.149~158 (2018)
- Kim HR, "Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses", Archives of Toxicology, 90(3), pp.617~632 (2016)
- Kim HR, "The role of NF-κB signaling pathway in polyhexamethylene guanidine phosphate induced inflammatory response in mouse macrophage RAW264.7 cells", Toxicology Letters, 233(2), pp.148~155 (2015)
- Kim S, "Humidifier Disinfectant Disaster, what do we know and what are left to be clarified?", Environmental Health and Toxicology (2016)
- Nordenhäll C, "Airway inflammation following exposure to diesel exhaust: a study of time kinetics using induced sputum", European Respiratory Journal, 15(6), pp.1046~1051 (2000)
- OECD, "OECD guideline for testing of chemicals, Section 4: Health effects, Test No. 436. Acute Inhalation Toxicity – Acute Toxic Class Method", OECD, ~ (2009)
- OECD, "OECD guideline for testing of chemicals, Section 4: Health effects, Test No. 431. In vitro skin corrosion: reconstructed human epidermis (RHE) test method", OECD, ~ (2019)
- OECD, "OECD guideline for testing of chemicals, Section 4: Health effects, Test No. 492. Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage", OECD, ~ (2019)
- Sugita-Konishi Y, "Differential upregulation of TNF-alpha, IL-6, and IL-8 production by deoxynivalenol (vomitoxin) and other 8-ketotrichothecenes in a human macrophage model", Journal of Toxicology and Environmental Health, Part A, 64(8), pp.619~636 (2001)
- Tappe D, "Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase", Medical Microbiology and Immunology, 205(3), pp.269~273 (2016)